Identification of differentially expressed proteins in atherosclerotic aorta and effect of vitamin E

Journal of Proteomics

Volumn 92, Issue , 2013, Pages 260-273

  Kaga, Elif ^a   Karademir, Betul ^a   Baykal, Ahmet Tarik ^b   Ozer, Nesrin Kartal ^a  

^a MARMARA UNIVERSITY   (Turkey)

^b MATERIALS INSTITUTE   (Turkey)

Author keywords

Atherosclerosis; Hypercholesterolemia; Proteomic; Vitamin E

Indexed keywords

ALPHA ACTININ 1; ALPHA ACTININ 4; ALPHA ENOLASE; ALPHA TOCOPHEROL; ALPHA TROPOMYOSIN; APOLIPOPROTEIN A1; APOLIPOPROTEIN E; BIGLYCAN; CARBONATE DEHYDRATASE II; CHOLESTEROL; CYTOSKELETON PROTEIN; DECORIN; DESMIN; ELONGATION FACTOR 1ALPHA; FETUIN A; FIBRILLIN 1; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; LIPOCORTIN 5; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA ALPHA; PROTEIN 14 3 3 ZETA DELTA; SCLEROPROTEIN; SERUM ALBUMIN; THIOREDOXIN; TRANSGELIN; TRYPSIN; UNCLASSIFIED DRUG; VIMENTIN; VIMENTIN 4;

AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; AORTA ATHEROSCLEROSIS; ARTICLE; ATHEROGENESIS; CELLULAR DISTRIBUTION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL DIET; CONTROLLED STUDY; INTRACELLULAR SIGNALING; LIPID METABOLISM; LIQUID CHROMATOGRAPHY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN STRUCTURE; RABBIT; SIGNAL TRANSDUCTION; TANDEM MASS SPECTROMETRY; UNINDEXED SEQUENCE; UPREGULATION; VITAMIN BLOOD LEVEL;

ORYCTOLAGUS CUNICULUS;

ABCA1; ATHEROSCLEROSIS; ATP-BINDING CASSETTE TRANSPORTER A1; C-JUN N-TERMINAL KINASE; FASP; FILTER AIDED SAMPLE PREPARATION PROTOCOL; H(2)O(2); HYDROGEN PEROXIDE; HYPERCHOLESTEROLEMIA; IAA; IODOACETAMIDE; JNK; LDL; LOW-DENSITY LIPOPROTEIN; MITOGEN-ACTIVATED PROTEIN KINASE P38 ALPHA; NA(3)VO(4); NADPH; NAF; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; OXIDIZED LOW-DENSITY LIPOPROTEIN; OXLDL; P38 MAPK; PEROXIREDOXIN; PKC; PRDX; PROTEIN KINASE C; PROTEOMIC; SMC; SMOOTH MUSCLE CELL; SODIUM FLUORIDE; SODIUM ORTHOVANADATE; ULTRA PRESSURE LIQUID CHROMATOGRAPHY; UNIPROT; UNIVERSAL PROTEIN RESOURCE; UPLC; VITAMIN E;

14-3-3 PROTEINS; ANIMALS; ANTIOXIDANTS; AORTA; AORTIC DISEASES; APOLIPOPROTEIN A-I; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BIGLYCAN; GENE EXPRESSION REGULATION; HYPERCHOLESTEROLEMIA; LIPOPROTEINS, LDL; MALE; PEROXIREDOXINS; RABBITS; THIOREDOXINS; TROPOMYOSIN; VIMENTIN; VITAMIN E;

EID: 84886947119     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2013.06.015     Document Type: Article

References (64)

1. Sharrett A.R., Ballantyne C.M., Coady S.A., Heiss G., Sorlie P.D., Catellier D., et al. Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study. Circulation Sep 4 2001, 104(10):1108-1113.
2. Tracy R.P., Tracy P.B. New views on the relationship of plasma lipids to cardiovascular disease. Circulation Mar 18 1997, 95(6):1347-1348.
3. Mayr M., Mayr U., Chung Y.L., Yin X., Griffiths J.R., Xu Q. Vascular proteomics: linking proteomic and metabolomic changes. Proteomics Dec 2004, 4(12):3751-3761.
4. Catalgol B., Kartal O.N. Lipid rafts and redox regulation of cellular signaling in cholesterol induced atherosclerosis. Curr Cardiol Rev Nov 2010, 6(4):309-324.
5. Stocker R., Keaney J.F. Role of oxidative modifications in atherosclerosis. Physiol Rev Oct 2004, 84(4):1381-1478.
6. Grieve D.J., Byrne J.A., Cave A.C., Shah A.M. Role of oxidative stress in cardiac remodelling after myocardial infarction. Heart Lung Circ Jun 2004, 13(2):132-138.
7. Murdoch C.E., Zhang M., Cave A.C., Shah A.M. NADPH oxidase-dependent redox signalling in cardiac hypertrophy, remodelling and failure. Cardiovasc Res Jul 15 2006, 71(2):208-215.
8. Fortuno A., San J.G., Moreno M.U., Diez J., Zalba G. Oxidative stress and vascular remodelling. Exp Physiol Jul 2005, 90(4):457-462.
9. Singh U., Jialal I. Oxidative stress and atherosclerosis. Pathophysiology Aug 2006, 13(3):129-142.
10. Stephens N.G., Parsons A., Schofield P.M., Kelly F., Cheeseman K., Mitchinson M.J. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet Mar 23 1996, 347(9004):781-786.
11. Rimm E.B., Stampfer M.J., Ascherio A., Giovannucci E., Colditz G.A., Willett W.C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med May 20 1993, 328(20):1450-1456.
12. Zingg J.M., Azzi A. Non-antioxidant activities of vitamin E. Curr Med Chem May 2004, 11(9):1113-1133.
13. Azzi A., Cantoni O., Ozer N., Boscoboinik D., Spycher S. The role of hydrogen peroxide and RRR-alpha-tocopherol in smooth muscle cell proliferation. Cell Death Differ Jan 1996, 3(1):79-90.
14. Ozer N.K., Palozza P., Boscoboinik D., Azzi A. d-alpha-Tocopherol inhibits low density lipoprotein induced proliferation and protein kinase C activity in vascular smooth muscle cells. FEBS Lett May 17 1993, 322(3):307-310.
15. Azzi A., Ricciarelli R., Zingg J.M. Non-antioxidant molecular functions of alpha-tocopherol (vitamin E). FEBS Lett May 22 2002, 519(1-3):8-10.
16. Lander E.S., Linton L.M., Birren B., et al. Initial sequencing and analysis of the human genome. Nature Feb 15 2001, 409(6822):860-921.
17. Venter J.C., Adams M.D., Myers E.W., et al. The sequence of the human genome. Science Feb 16 2001, 291(5507):1304-1351.
18. Waterston R.H., Lindblad-Toh K., Birney E., et al. Initial sequencing and comparative analysis of the mouse genome. Nature Dec 5 2002, 420(6915):520-562.
19. Aebersold R., Mann M. Mass spectrometry-based proteomics. Nature Mar 13 2003, 422(6928):198-207.
20. Ozer N.K., Negis Y., Aytan N., et al. Vitamin E inhibits CD36 scavenger receptor expression in hypercholesterolemic rabbits. Atherosclerosis Jan 2006, 184(1):15-20.
21. Nierenberg D.W., Nann S.L. A method for determining concentrations of retinol, tocopherol, and five carotenoids in human plasma and tissue samples. Am J Clin Nutr Aug 1992, 56(2):417-426.
22. Wisniewski J.R., Zougman A., Nagaraj N., Mann M. Universal sample preparation method for proteome analysis. Nat Methods May 2009, 6(5):359-362.
23. Hacariz O., Sayers G., Baykal A.T. A proteomic approach to investigate the distribution and abundance of surface and internal Fasciola hepatica proteins during the chronic stage of natural liver fluke infection in cattle. J Proteome Res Jul 6 2012, 11(7):3592-3604.
24. Cheng F.Y., Blackburn K., Lin Y.M., Goshe M.B., Williamson J.D. Absolute protein quantification by LC/MS(E) for global analysis of salicylic acid-induced plant protein secretion responses. J Proteome Res Jan 2009, 8(1):82-93.
25. Silva J.C., Gorenstein M.V., Li G.Z., Vissers J.P., Geromanos S.J. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteomics Jan 2006, 5(1):144-156.
26. Bostanci N., Heywood W., Mills K., Parkar M., Nibali L., Donos N. Application of label-free absolute quantitative proteomics in human gingival crevicular fluid by LC/MS E (gingival exudatome). J Proteome Res May 7 2010, 9(5):2191-2199.
27. D'Aguanno S., D'Alessandro A., Pieroni L., et al. New insights into neuroblastoma cisplatin resistance: a comparative proteomic and meta-mining investigation. J Proteome Res Feb 4 2011, 10(2):416-428.
28. Vissers J.P., Langridge J.I., Aerts J.M. Analysis and quantification of diagnostic serum markers and protein signatures for Gaucher disease. Mol Cell Proteomics May 2007, 6(5):755-766.
29. Kirac D., Negis Y., Ozer N.K. Vitamin E attenuates homocysteine and cholesterol induced damage in rat aorta. Cardiovasc Pathol Apr 30 2013.
30. Jialal I., Devaraj S. The role of oxidized low density lipoprotein in atherogenesis. J Nutr Apr 1996, 126(4 Suppl.):1053S-1057S.
31. Mardones P., Rigotti A. Cellular mechanisms of vitamin E uptake: relevance in alpha-tocopherol metabolism and potential implications for disease. J Nutr Biochem May 2004, 15(5):252-260.
32. Azzi A., Boscoboinik D., Marilley D., Ozer N.K., Stauble B., Tasinato A. Vitamin E: a sensor and an information transducer of the cell oxidation state. Am J Clin Nutr Dec 1995, 62(6 Suppl.):1337S-1346S.
33. Kaul N., Devaraj S., Jialal I. Alpha-tocopherol and atherosclerosis. Exp Biol Med (Maywood) Jan 2001, 226(1):5-12.
34. Ricciarelli R., Zingg J.M., Azzi A. Vitamin E: protective role of a Janus molecule. FASEB J Nov 2001, 15(13):2314-2325.
35. Ozer N.K., Azzi A. Effect of vitamin E on the development of atherosclerosis. Toxicology Aug 7 2000, 148(2-3):179-185.
36. Tan D.T., Khor H.T., Low W.H., Ali A., Gapor A. Effect of a palm-oil-vitamin E concentrate on the serum and lipoprotein lipids in humans. Am J Clin Nutr Apr 1991, 53(4 Suppl.):1027S-1030S.
37. Von Zur M.C., Schiffer E., Sackmann C., et al. Urine proteome analysis reflects atherosclerotic disease in an ApoE-/- mouse model and allows the discovery of new candidate biomarkers in mouse and human atherosclerosis. Mol Cell Proteomics Jul 2012, 11(7):M111.
38. Ridker P.M., Hennekens C.H., Buring J.E., Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med Mar 23 2000, 342(12):836-843.
39. Vivanco F., Martin-Ventura J.L., Duran M.C., et al. Quest for novel cardiovascular biomarkers by proteomic analysis. J Proteome Res Jul 2005, 4(4):1181-1191.
40. von E.A. Cholesterol efflux from macrophages and other cells. Curr Opin Lipidol Oct 1996, 7(5):308-319.
41. Traber M.G., Atkinson J. Vitamin E, antioxidant and nothing more. Free Radic Biol Med Jul 1 2007, 43(1):4-15.
42. Qian J., Atkinson J., Manor D. Biochemical consequences of heritable mutations in the alpha-tocopherol transfer protein. Biochemistry Jul 11 2006, 45(27):8236-8242.
43. Huebbe P., Jofre-Monseny L., Rimbach G. Alpha-tocopherol transport in the lung is affected by the apoE genotype - studies in transgenic apoE3 and apoE4 mice. IUBMB Life Apr 2009, 61(4):453-456.
44. Greenow K., Pearce N.J., Ramji D.P. The key role of apolipoprotein E in atherosclerosis. J Mol Med (Berl) May 2005, 83(5):329-342.
45. Mayr M., Chung Y.L., Mayr U., et al. Proteomic and metabolomic analyses of atherosclerotic vessels from apolipoprotein E-deficient mice reveal alterations in inflammation, oxidative stress, and energy metabolism. Arterioscler Thromb Vasc Biol Oct 2005, 25(10):2135-2142.
46. Madrigal-Matute J., Martinez-Pinna R., Fernandez-Garcia C.E., et al. Cell stress proteins in atherothrombosis. Oxid Med Cell Longev 2012, 2012:1-10.
47. Kisucka J., Chauhan A.K., Patten I.S., et al. Peroxiredoxin1 prevents excessive endothelial activation and early atherosclerosis. Circ Res Sep 12 2008, 103(6):598-605.
48. Almofti M.R., Huang Z., Yang P., Rui Y., Yang P. Proteomic analysis of rat aorta during atherosclerosis induced by high cholesterol diet and injection of vitamin D3. Clin Exp Pharmacol Physiol Apr 2006, 33(4):305-309.
49. Park J.G., Yoo J.Y., Jeong S.J., et al. Peroxiredoxin 2 deficiency exacerbates atherosclerosis in apolipoprotein E-deficient mice. Circ Res Sep 16 2011, 109(7):739-749.
50. Dahlan H.M., Karsani S.A., Rahman M.A., Hamid N.A., Top A.G., Ngah W.Z. Proteomic analysis reveals that treatment with tocotrienols reverses the effect of H(2)O(2) exposure on peroxiredoxin expression in human lymphocytes from young and old individuals. J Nutr Biochem Jul 2012, 23(7):741-751.
51. Ricciarelli R., Tasinato A., Clement S., Ozer N.K., Boscoboinik D., Azzi A. alpha-Tocopherol specifically inactivates cellular protein kinase C alpha by changing its phosphorylation state. Biochem J Aug 15 1998, 334(Pt 1):243-249.
52. Hess A., Wijayanti N., Neuschafer-Rube A.P., Katz N., Kietzmann T., Immenschuh S. Phorbol ester-dependent activation of peroxiredoxin I gene expression via a protein kinase C, Ras, p38 mitogen-activated protein kinase signaling pathway. J Biol Chem Nov 14 2003, 278(46):45419-45434.
53. Wheeler-Jones C.P., Learmonth M.P., Martin H., Aitken A. Identification of 14-3-3 proteins in human platelets: effects of synthetic peptides on protein kinase C activation. Biochem J Apr 1 1996, 315(Pt 1):41-47.
54. Ozer N.K., Boscoboinik D., Azzi A. New roles of low density lipoproteins and vitamin E in the pathogenesis of atherosclerosis. Biochem Mol Biol Int Jan 1995, 35(1):117-124.
55. Azzi A., Boscoboinik D., Clement S., et al. Signalling functions of alpha-tocopherol in smooth muscle cells. Int J Vitam Nutr Res 1997, 67(5):343-349.
56. Fach E.M., Garulacan L.A., Gao J., et al. In vitro biomarker discovery for atherosclerosis by proteomics. Mol Cell Proteomics Dec 2004, 3(12):1200-1210.
57. Kunjathoor V.V., Chiu D.S., O'Brien K.D., LeBoeuf R.C. Accumulation of biglycan and perlecan, but not versican, in lesions of murine models of atherosclerosis. Arterioscler Thromb Vasc Biol Mar 1 2002, 22(3):462-468.
58. Chang M.Y., Potter-Perigo S., Tsoi C., Chait A., Wight T.N. Oxidized low density lipoproteins regulate synthesis of monkey aortic smooth muscle cell proteoglycans that have enhanced native low density lipoprotein binding properties. J Biol Chem Feb 18 2000, 275(7):4766-4773.
59. Goti D., Balazs Z., Panzenboeck U., et al. Effects of lipoprotein lipase on uptake and transcytosis of low density lipoprotein (LDL) and LDL-associated alpha-tocopherol in a porcine in vitro blood-brain barrier model. J Biol Chem Aug 9 2002, 277(32):28537-28544.
60. Samanta S., Anderson K., Moran S., Hawke D., Gorenstein D., Fornage M. Characterization of a human 12/15-lipoxygenase promoter variant associated with atherosclerosis identifies vimentin as a promoter binding protein. PLoS One 2012, 7(8):1-10.
61. Kang J.H., Kim H.T., Choi M.S., et al. Proteome analysis of human monocytic THP-1 cells primed with oxidized low-density lipoproteins. Proteomics Feb 2006, 6(4):1261-1273.
62. Lees J.G., Ching Y.W., Adams D.H., Bach C.T., Samuel M.S., Kee A.J., et al. Tropomyosin regulates cell migration during skin wound healing. J Invest Dermatol May 2013, 133(5):1330-1339.
63. Aratri E., Spycher S.E., Breyer I., Azzi A. Modulation of alpha-tropomyosin expression by alpha-tocopherol in rat vascular smooth muscle cells. FEBS Lett Mar 19 1999, 447(1):91-94.
64. Oommen S., Vasu V.T., Leonard S.W., Traber M.G., Cross C.E., Gohil K. Genome wide responses of murine lungs to dietary alpha-tocopherol. Free Radic Res Jan 2007, 41(1):98-109.